Nursing- Annotated Bibliography

Nursing- Annotated Bibliography

Depression is a major comorbid condition in patients with chronic medical (Gold et al., 2020). Depression, besides being a common comorbidity, is also a risk factor for developing chronic medical issues such as heart failure (Sbolli et al., 2020). Comorbid depression increases nonadherence to medication and treatments for medical diseases (Gaspar et al., 2019). Therefore, managing comorbid depression requires both pharmacotherapy and psychotherapy approaches to improve the outcomes of the depression and the related conditions. This article presents an annotated bibliography of peer-reviewed articles on the application of pharmacotherapy and psychotherapy to manage comorbid depression.

Annotated Bibliography

Chen, C., & Shan, W. (2019). Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis. Psychiatry Research, 281. 112595. https://doi.org/10.1016/j.psychres.2019.112595

This article presents a systematic review and network meta-analysis of 1213 articles comparing the efficacy and safety profiles of pharmacological and non-pharmacological treatments for major depressive disorder (MDD) in adults. These treatments include acupuncture, mirtazapine, herbal medicine, venlafaxine, physical exercise, cognitive-behavioral therapy (CBT), bupropion, fluoxetine, and vortioxetine. Acupuncture, mirtazapine, herbal medicine, and cognitive-behavioral therapy (CBT) were found to be most effective in MDD treatment. Pharmacological treatments for MDD are noted as the least safe. The article is informative and can help mental health practitioners design comprehensive care plans for MDD patients by comparing pharmacological and non-pharmacological agents’ efficacy and safety profiles.

Croatto, G., Vancampfort, D., Miola, A., Olivola, M., Fiedorowicz, J. G., Firth, J., Alexinschi, O., Gaina, M. A., Makkai, V., Soares, F. C., Cavaliere, L., Vianello, G., Stubbs, B., Fusar-Poli, P., Carvalho, A. F., Vieta, E., Cortese, S., Shin, J. Il, Correll, C. U., & Solmi, M. (2023). The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomized controlled trials. Molecular Psychiatry, 28(1). 369-390. https://doi.org/10.1038/s41380-022-01770-w

In this umbrella review of evidence from 97 randomized controlled trials, the authors aim to identify interventions that have the potential to improve physical health in people with mood disorders with a high risk of comorbid medical diseases. Both pharmacological and non-pharmacological interventions such as SSRIs, antidepressants/antipsychotics, psychological therapies, and exercise were noted as effective. However, they differ in their safety profiles. Conclusively, the priority for selecting interventions should be based on their benefit and risk profiles. This article highlights the factors to consider in intervention prioritization and the need to use evidence from diverse resources in caring for mood disorder patients.

Cunningham, J. E. A., Stamp, J. A., & Shapiro, C. M. (2019). Sleep and major depressive disorder: a review of non-pharmacological chronotherapeutic treatments for unipolar depression. Sleep Medicine, 61. 6-18. https://doi.org/10.1016/j.sleep.2019.04.012

This article presents a critical literature review of evidence on the potential of chronotherapies in treating depression. The authors focus on evidence on bright light therapy (BLT) and the combination of BLT with other chronotherapeutic treatments, sleep deprivation/wake therapy, and sleep phase advances. The review presents BLT, when applied after waking, as more effective in treating depression than antidepressant medications. Combined BLT and other chronotherapies are more effective than when used individually. This article is useful as it presents evidence on combined chronotherapies in treating depression and sets a precedent for further research to improve evidence on the use of chronotherapies.

Liu, Q., Li, R., Qu, W., Li, B., Yang, W., & Cui, R. (2019). Pharmacological and non-pharmacological interventions of depression after traumatic brain injury: A systematic review. European Journal of Pharmacology, 865. 172775. https://doi.org/10.1016/j.ejphar.2019.172775

This systematic review article presents a discussion on the possible pathology of depression from traumatic brain injury (TBI) and a review of recent evidence on pharmacological and non-pharmacological interventions for treating TBI-associated depression. The authors identify depression as a common incidence following a TBI. Although pharmacological and non-pharmacological interventions moderately improve depressive symptoms in TBI patients, evidence is inconclusive, and more focused research is needed. This article is important in efforts to manage TBI-associated depression as it identifies critical evidence gaps and provides aspects of post-TBI depression to consider in future research, such as its pathophysiology and efficacy mechanisms of treatments.

Maffioletti, E., Minelli, A., Tardito, D., & Gennarelli, M. (2020). Blues in the brain and beyond Molecular bases of major depressive disorder and relative pharmacological and non-pharmacological treatments. Genes, 11(9). 1089. https://doi.org/10.3390/genes11091089

This narrative review critically evaluates evidence on the molecular bases of major depressive disorder (MDD) and the available pharmacological and non-pharmacological treatments. The authors explored the existing pathogenic hypotheses on the molecular mechanisms of MDD with the aim of simplifying the complex development mechanism of MDD. The review of evidence also aims to determine how various treatment approaches are effective in treating MDD. The effectiveness of treatment approaches, whether pharmacological or non-pharmacological, is based on the underlying mechanism of MDD development. The article is important because it highlights the molecular bases of MDD and identifies the need for further research aimed at improving the understanding of MDD.

 References

Chen, C., & Shan, W. (2019). Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis. Psychiatry Research, 281. 112595. https://doi.org/10.1016/j.psychres.2019.112595

Croatto, G., Vancampfort, D., Miola, A., Olivola, M., Fiedorowicz, J. G., Firth, J., Alexinschi, O., Gaina, M. A., Makkai, V., Soares, F. C., Cavaliere, L., Vianello, G., Stubbs, B., Fusar-Poli, P., Carvalho, A. F., Vieta, E., Cortese, S., Shin, J. Il, Correll, C. U., & Solmi, M. (2023). The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomized controlled trials. Molecular Psychiatry, 28(1). 369-390. https://doi.org/10.1038/s41380-022-01770-w

Cunningham, J. E. A., Stamp, J. A., & Shapiro, C. M. (2019). Sleep and major depressive disorder: a review of non-pharmacological chronotherapeutic treatments for unipolar depression. Sleep Medicine, 61. 6-18. https://doi.org/10.1016/j.sleep.2019.04.012

Gaspar, F. W., Zaidel, C. S., & Dewa, C. S. (2019). Rates and determinants of use of pharmacotherapy and psychotherapy by patients with major depressive disorder. Psychiatric Services, 70(4). 262-270. https://doi.org/10.1176/appi.ps.201800275

Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020). Comorbid depression in medical diseases. Nature Reviews Disease Primers, 6(1). 69. https://doi.org/10.1038/s41572-020-0200-2

Liu, Q., Li, R., Qu, W., Li, B., Yang, W., & Cui, R. (2019). Pharmacological and non-pharmacological interventions of depression after traumatic brain injury: A systematic review. European Journal of Pharmacology, 865. 172775. https://doi.org/10.1016/j.ejphar.2019.172775

Maffioletti, E., Minelli, A., Tardito, D., & Gennarelli, M. (2020). Blues in the brain and beyond: Molecular bases of major depressive disorder and relative pharmacological and non-pharmacological treatments. Genes, 11(9). 1089. https://doi.org/10.3390/genes11091089

Sbolli, M., Fiuzat, M., Cani, D., & O’Connor, C. M. (2020). Depression and heart failure: the lonely comorbidity. European Journal of Heart Failure, 22(11). 2007-2017. https://doi.org/10.1002/

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

---

This week, you will complete a literature search, find 8 research articles from peer-reviewed journals, and submit an APA annotated bibliography on 5 of them. These are to be peer-reviewed articles no older than 5 years.

Referencing your search findings, review the literature for articles no older than 5 years that discuss
evidence-based practice for your selected population and your problem focus. Include both medical
and nursing articles. You should have no less than 8 articles from peer-reviewed journals, NOT
websites. If you have an article that is older than 5 years, consult with your instructor.
Choose 5 of the 8 articles and complete an APA annotated bibliography.